ARWR R&D Expenses
Arrowhead Pharmaceuticals Inc · R&D Expenses
ARWR R&D Expenses
Latest reported$723.37Mperiod ending
ARWR TTM R&D Expenses ($0.00 → $723.37M)
TTM R&D Expenses
High-resolution chart · PNG
ARWR r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 723,366,000 | |
| 687,511,000 | |
| 647,360,000 | |
| 607,159,000 | |
| 563,864,000 | |
| 549,658,000 | |
| 513,578,000 | |
| 489,216,000 | |
| 454,225,000 | |
| 397,949,000 | |
| 373,543,000 | |
| 342,312,000 | |
| 327,032,000 | |
| 305,126,000 | |
| 306,314,000 | |
| 288,500,000 | |
| 273,145,000 | |
| 262,490,000 | |
| 233,383,000 | |
| 206,343,000 | |
| 182,442,503 | |
| 154,308,237 | |
| 137,835,984 | |
| 123,543,716 | |
| 103,985,142 | |
| 91,087,669 | |
| 82,491,582 | |
| 76,628,541 | |
| 69,092,097 | |
| 61,681,248 | |
| 52,909,942 | |
| 44,942,154 | |
| 38,452,074 | |
| 34,475,678 | |
| 30,595,149 | |
| 31,690,297 | |
| 35,081,490 | |
| 37,598,669 | |
| 40,642,670 | |
| 41,454,452 | |
| 40,172,290 | |
| 38,239,495 | |
| 50,002,249 | |
| 57,407,728 | |
| 55,436,603 | |
| 54,338,403 | |
| 37,771,269 | |
| 23,159,971 | |
| 17,989,075 | |
| 13,353,402 | |
| 10,261,975 | |
| 8,705,627 | |
| 7,502,673 | |
| 6,965,382 | |
| 6,199,054 | |
| 5,391,462 | |
| 3,856,631 | |
| 3,003,013 | |
| 1,784,980 | |
| 3,277,761 | |
| 3,022,966 | |
| 2,780,691 | |
| 2,864,466 | |
| 880,399 | |
| 1,642,302 | |
| 4,028,634 | |
| 5,310,749 | |
| 8,921,265 | |
| 13,534,160 | |
| 14,373,908 | |
| 14,557,397 | |
| 12,333,782 | |
| 13,118,085 | |
| 18,332,063 | |
| 21,107,501 | |
| 20,930,546 | |
| 19,158,723 | |
| 11,656,214 | |
| 10,308,402 | |
| 11,463,947 | |
| 8,080,677 | |
| 8,364,566 | |
| 5,685,941 | |
| 3,690,568 | |
| 2,790,434 | |
| 1,677,888 | |
| 1,380,510 | |
| 793,354 | |
| 434,645 | |
| 202,410 | |
| 60,750 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |